1 / 12

Virtual Clinical Trials Market

Virtual Clinical Trials (VCT) are a new method of directing clinical trials which is inclusive of web platforms (informed consent, recruitment, adverse reactions, counseling and measurement of endpoints) and taking advantage of technology such as monitoring devices, apps and others. VCT also allows participant to be home-based at all clinical trial stage. VCT are operationally feasible and have lower drop-out rates, higher recruitment rates, better compliance and are faster than traditional method.

Ronald15
Télécharger la présentation

Virtual Clinical Trials Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Virtual Clinical Trials Market Market Size Worth $13.78 Billion by 2027 | CAGR: 12.6%

  2. Virtual Clinical Trials Market Size Worth $13.78 Billion by 2027 | CAGR: 12.6% “As per Polaris Market Research report, Virtual Clinical Trials Market is attending major innovations & transformations and is projected to reach $13.78 Billion by 2027 | CAGR: 12.6% 6% during the conjecture period 2021 to 2028.” The global Virtual Clinical Trials Market report scrutinizes the present situation and development prognosis of the market. The report offers a complete knowledge of key parameters such as market size, share and growth, trends, cost structure, and comprehensive and statistical data in the global Virtual Clinical Trials Market. Also, the market overview section of the report holds an in-depth analysis of current and future trends, analyzing the data on a historical basis and forecasted data till the year 2028. The report traces key market drivers, covering potentially lucrative opportunities and challenges as well as drivers, obstacles, issues, and risks. ➢Virtual Clinical Trials Market Report Scope: The global Virtual Clinical Trials Market is segmented ByDesign, By Indication, By Phases, By Region. The research report analyzes the most important trends related to the different segments that help to explain the market. The report additionally surveys both developed & developing regions considered for global Virtual Clinical Trials Market research. The regional analysis engages readers with a comprehensive overview of various countries and regions to help players plan effective expansion strategies. The report outlines the noteworthy factors, such as driving factors and challenges, that will explain the market’s future growth. Also, it covers an exhaustive coverage of major industry drivers, restraints, and their impact on global Virtual Clinical Trials Market growth during the forecast period from 2021-2028. The market research assists in studying the key plans, initiatives, and strategies for the development of the market. - 2 -

  3. Virtual Clinical Trials Market Size Worth $13.78 Billion by 2027 | CAGR: 12.6% By Design By Indication By Phases By Region •Observational •CNS •Phase I •North America (U.S., Canada) •Autoimmune/Inflammation •Phase II •Europe (France, Germany, UK, Italy, Spain, Netherlands, Trials •Interventional •Cardiovascular Disease •Phase III Austria) •Asia Pacific (Japan, China, India, Malaysia, Indonesia. Trials •Metabolic/Endocrinology •Phase IV •Expanded South Korea) •Infectious Disease •Latin America (Brazil, Mexico, Argentina) Access •Oncology Trials •MEA (Saudi Arabia, UAE, Israel, South Africa) •Genitourinary •Ophthalmology ➢COVID-19 Impact Analysis for Virtual Clinical Trials Market The market has also been affected by the recent COVID-19 pandemic and is expected to experience its long- term effects over the forecast period. Extensive evaluation of the effect of the COVID-19 pandemic is given to uncover the major issues and potential paths forward. The report merges the customer spending habits, business target, dynamics of current market forces, re-routing of the supply chain, and competitors in the global Virtual Clinical Trials Market as a thorough analysis. The report serves overall estimation, insights, and forecasts, considering the COVID-19 impact on the market. Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic impacting the the Virtual Clinical Trials Market across different regions and how major players are building strategies to mitigate the adverse effect of the pandemic and take benefit of emerging opportunities ➢Regional Outlook In terms of geography, the region dominated the market with its higher revenue share contribution. The driving factors for this regional market growth include the current technological advancements in the industry, growing economic stability, huge government investments, and rising awareness related to the benefits of the product/service. ➢Browse Detailed Research Report on Virtual Clinical Trials Market Analysis: https://www.polarismarketresearch.com/industry-analysis/virtual-clinical-trials-market ➢Competitive Landscape - 3 -

  4. Virtual Clinical Trials Market Size Worth $13.78 Billion by 2027 | CAGR: 12.6% The report completely profiles prominent market players or industrialists covering company profile, product specifications, production capacity/sales, revenue, price, and gross margin & sales. Here you will find a comprehensive analysis of the competitive landscape and detailed information on vendors and factors that will challenge the growth of major vendors. The section highlights key points such as regional segmentation, major investments, and details of historical, present, and projected revenues. the product portfolio, market explanation, and classification are indicated. According to Polaris Market Research, the leading players with a noteworthy dominance in the Virtual Clinical Trials Market include LEO Innovation Lab, Covance Inc., CRF Health, Oracle Corporation, Medable, Inc., Paraxel International, Clinical Ink, Inc., PRA Health Sciences, Science 37 and ICON plc. https://www.polarismarketresearch.com/industry-analysis/virtual-clinical-trials- Request for sample: market/request-for-sample Table of Contents 1.Introduction 1.1.Report Description 1.1.1.Objectives of the Study 1.1.2.Market Scope 1.1.3.Assumptions 1.2.Stakeholders 2.Executive Summary 2.1.Market Highlights 3.Research Methodology 3.1.Overview 3.1.1.Data Mining 3.2.Data Sources 3.2.1.Primary Sources 3.2.2.Secondary Sources 4.Virtual Clinical Trials Market Insights 4.1.Virtual Clinical Trials – Industry snapshot 4.2.Virtual Clinical Trials Market Dynamics 4.2.1.Drivers and Opportunities 4.2.1.1. Need for digitization in clinical trials 4.2.1.2. Fear among clinical investigators for COVID-19 4.2.2.Restraints and Challenges - 4 -

  5. Virtual Clinical Trials Market Size Worth $13.78 Billion by 2027 | CAGR: 12.6% 4.2.2.1. High upfront costs 4.3.Porter’s Five Forces Analysis 4.3.1.Bargaining Power of Suppliers (Moderate) 4.3.2.Threats of New Entrants: (Low) 4.3.3.Bargaining Power of Buyers (Moderate) 4.3.4.Threat of Substitute (Moderate) 4.3.5.Rivalry among existing firms (High) 4.4.PESTLE Analysis 4.5.Virtual Clinical Trials Market Industry trends 5.Virtual Clinical Trials Market Assessment by Design 5.1.Key Findings 5.2.Introduction 5.2.1.Global Virtual Clinical Trials Market, By Design, 2016 - 2027 (USD Million) 5.3.Observational Trials 5.3.1.Global Virtual Clinical Trials Market, by Observational Trials, by Region, 2016- 2027 (USD Million) 5.4.Interventional Trials 5.4.1.Global Virtual Clinical Trials Market, by Interventional Trials, by Region, 2016- 2027 (USD Million) 5.5.Expanded Access Trials 5.5.1.Global Virtual Clinical Trials Market, by Expanded Access Trials, by Region, 2016- 2027 (USD Million) 6.Global Virtual Clinical Trials Market, by Indication 6.1.Key Findings 6.2.Introduction 6.2.1.Global Virtual Clinical Trials Market, By Indication, 2016 - 2027 (USD Million) 6.3.CNS 6.3.1.Global Virtual Clinical Trials Market, by CNS, By Region, 2016- 2027 (USD Million) 6.4.Autoimmune/Inflammation 6.4.1.Global Virtual Clinical Trials Market, by Autoimmune/Inflammation, by Region, 2016- 2027 (USD Million) 6.5.Cardiovascular Disease 6.5.1.Global Virtual Clinical Trials Market, by Cardiovascular Disease, by Region, 2016- 2027 (USD Million) 6.6.Metabolic/Endocrinology 6.6.1.Global Virtual Clinical Trials Market, by Metabolic/Endocrinology, by Region, 2016- 2027 (USD Million) - 5 -

  6. Virtual Clinical Trials Market Size Worth $13.78 Billion by 2027 | CAGR: 12.6% 6.7.Infectious Disease 6.7.1.Global Virtual Clinical Trials Market, by Infectious Disease, by Region, 2016- 2027 (USD Million) 6.8.Oncology 6.8.1.Global Virtual Clinical Trials Market, by Oncology, by Region, 2016- 2027 (USD Million) 6.9.Genitourinary 6.9.1.Global Virtual Clinical Trials Market, by Genitourinary, by Region, 2016- 2027 (USD Million) 6.10. Ophthalmology 6.10.1.Global Virtual Clinical Trials Market, by Ophthalmology, by Region, 2016- 2027 (USD Million) 7.Global Virtual Clinical Trials Market, by Phases 7.1.Key Findings 7.2.Introduction 7.2.1.Global Virtual Clinical Trials Market, By Phases, 2016 - 2027 (USD Million) 7.3.Phase I 7.3.1.Global Virtual Clinical Trials Market, by Phase I, By Region, 2016- 2027 (USD Million) 7.4.Phase II 7.4.1.Global Virtual Clinical Trials Market, by Phase II, by Region, 2016- 2027 (USD Million) 7.5.Phase III 7.5.1.Global Virtual Clinical Trials Market, by Phase III, by Region, 2016- 2027 (USD Million) 7.6.Phase IV 7.6.1.Global Virtual Clinical Trials Market, by Phase IV, by Region, 2016- 2027 (USD Million) 8.Virtual Clinical Trials Market Assessment by Geography 8.1.Key findings 8.2.Introduction 8.2.1.Virtual Clinical Trials Market Assessment, By Geography, 2016- 2027 (USD Million) 8.3.Virtual Clinical Trials Market – North America 8.3.1.North America: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.3.2.North America: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) - 6 -

  7. Virtual Clinical Trials Market Size Worth $13.78 Billion by 2027 | CAGR: 12.6% 8.3.3.North America: Virtual Clinical Trials Market, By Phases, 2016 - 2027 (USD Million) 8.3.4.Virtual Clinical Trials Market – U.S. 8.3.4.1. U.S.: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.3.4.2. U.S.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.3.4.3. U.S.: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.3.5.Virtual Clinical Trials Market – Canada 8.3.5.1. Canada: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.3.5.2. Canada.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.3.5.3. Canada: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.4.Virtual Clinical Trials Market – Europe 8.4.1.Europe: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.4.2.Europe.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.4.3.Europe: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.4.4.Virtual Clinical Trials Market – UK 8.4.4.1. UK: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.4.4.2. UK.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.4.4.3. UK: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.4.5.Virtual Clinical Trials Market – France 8.4.5.1. France: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.4.5.2. France.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.4.5.3. France: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.4.6.Virtual Clinical Trials Market – Germany 8.4.6.1. Germany: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.4.6.2. Germany.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.4.6.3. Germany: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.4.7.Virtual Clinical Trials Market – Italy 8.4.7.1. Italy: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.4.7.2. Italy.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.4.7.3. Italy: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.4.8.Virtual Clinical Trials Market – Spain 8.4.8.1. Spain: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.4.8.2. Spain.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.4.8.3. Spain: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.4.9.Virtual Clinical Trials Market – Netherlands - 7 -

  8. Virtual Clinical Trials Market Size Worth $13.78 Billion by 2027 | CAGR: 12.6% 8.4.9.1. Netherlands: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.4.9.2. Netherlands.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.4.9.3. Netherlands: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.4.10.Virtual Clinical Trials Market – Austria 8.4.10.1.Austria: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.4.10.2.Austria.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.4.10.3.Austria: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.5.Virtual Clinical Trials Market – Asia-Pacific 8.5.1.Asia Pacific: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.5.2.Asia Pacific.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.5.3.Asia-pacific: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.5.4.Virtual Clinical Trials Market – China 8.5.4.1. China: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.5.4.2. China.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.5.4.3. China: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.5.5.Virtual Clinical Trials Market – India 8.5.5.1. India: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.5.5.2. India.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.5.5.3. India: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.5.6.Virtual Clinical Trials Market – Malaysia 8.5.6.1. Malaysia: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.5.6.2. Malaysia.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.5.6.3. Malaysia: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.5.7.Virtual Clinical Trials Market – Japan 8.5.7.1. Japan: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.5.7.2. Japan.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.5.7.3. Japan: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.5.8.Virtual Clinical Trials Market – Indonesia 8.5.8.1. Indonesia: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.5.8.2. Indonesia.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) - 8 -

  9. Virtual Clinical Trials Market Size Worth $13.78 Billion by 2027 | CAGR: 12.6% 8.5.8.3. Indonesia: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.5.9.Virtual Clinical Trials Market – South Korea 8.5.9.1. South Korea: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.5.9.2. South Korea.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.5.9.3. South Korea: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.6.Virtual Clinical Trials Market – Middle East & Africa 8.6.1.Middle East & Africa: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.6.2.Middle East & Africa.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.6.3.Middle East & Africa: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.6.4.Virtual Clinical Trials Market – Saudi Arabia 8.6.4.1. Saudi Arabia: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.6.4.2. Saudi Arabia.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.6.4.3. Saudi Arabia: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.6.5.Virtual Clinical Trials Market – UAE 8.6.5.1. UAE: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.6.5.2. UAE.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.6.5.3. UAE: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.6.6.Virtual Clinical Trials Market – Israel 8.6.6.1. Israel: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.6.6.2. Israel.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.6.6.3. Israel: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.6.7.Virtual Clinical Trials Market – South Africa 8.6.7.1. South Africa: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.6.7.2. South Africa.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.6.7.3. South Africa: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.7.Virtual Clinical Trials Market – Latin America 8.7.1.Latin America: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.7.2.Latin America.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) - 9 -

  10. Virtual Clinical Trials Market Size Worth $13.78 Billion by 2027 | CAGR: 12.6% 8.7.3.Latin America: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.7.4.Virtual Clinical Trials Market – Mexico 8.7.4.1. Mexico: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.7.4.2. Mexico.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.7.4.3. Mexico: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.7.5.Virtual Clinical Trials Market – Brazil 8.7.5.1. Brazil: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.7.5.2. Brazil.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.7.5.3. Brazil: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 8.7.6.Virtual Clinical Trials Market – Argentina 8.7.6.1. Argentina: Virtual Clinical Trials Market, By Design, 2016- 2027 (USD Million) 8.7.6.2. Argentina.: Virtual Clinical Trials Market, By Indication, 2016- 2027 (USD Million) 8.7.6.3. Argentina: Virtual Clinical Trials Market, By Phases, 2016- 2027 (USD Million) 9.Competitive Landscape 9.1.Expansion and Acquisition Analysis 9.1.1.Expansion Analysis 9.1.2.Acquisition Analysis 9.2.Partnerships/Collaborations/Agreements/Exhibitions 10.Company Profiles 10.1. LEO Innovation Lab 10.1.1.Company Overview 10.1.2.Financial Performance 10.1.3.Product Benchmarking 10.1.4.Recent Development 10.2. Covance Inc. 10.2.1.Company Overview 10.2.2.Financial Performance 10.2.3.Product Benchmarking 10.2.4.Recent Development 10.3. CRF Health 10.3.1.Company Overview 10.3.2.Financial Performance 10.3.3.Product Benchmarking 10.3.4.Recent Development 10.4. Oracle Corporation 10.4.1.Company Overview - 10 -

  11. Virtual Clinical Trials Market Size Worth $13.78 Billion by 2027 | CAGR: 12.6% 10.4.2.Financial Performance 10.4.3.Product Benchmarking 10.4.4.Recent Development 10.5. Medable, Inc. 10.5.1.Company Overview 10.5.2.Financial Performance 10.5.3.Product Benchmarking 10.5.4.Recent Development 10.6. Paraxel International 10.6.1.Company Overview 10.6.2.Financial Performance 10.6.3.Product Benchmarking 10.6.4.Recent Development 10.7. Clinical Ink, Inc. 10.7.1.Company Overview 10.7.2.Financial Performance 10.7.3.Product Benchmarking 10.7.4.Recent Development 10.8. PRA Health Sciences 10.8.1.Company Overview 10.8.2.Financial Performance 10.8.3.Product Benchmarking 10.8.4.Recent Development 10.9. Science 37, Inc. 10.9.1.Company Overview 10.9.2.Financial Performance 10.9.3.Product Benchmarking 10.9.4.Recent Development ➢Access Press Release on Virtual Clinical Trials Market: https://www.polarismarketresearch.com/press-releases/virtual-clinical-trials-market ➢About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby - 11 -

  12. Virtual Clinical Trials Market Size Worth $13.78 Billion by 2027 | CAGR: 12.6% helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 12 -

More Related